Stable cell line of human MET The MET gene, which codes for a receptor tyrosine kinase and the byproduct of the proto-oncogene MET, is designed to be expressed in the BaF3 cell line. The mature receptor's alpha and beta subunits are produced via proteolytic processing of the MET preproprotein. Hepatocyte growth factor (HGF) binding causes MET to dimerize and become activated. This process is important for cellular survival, embryogenesis, migration, and invasion.
Numerous malignancies, such as hepatocellular carcinoma, head and neck tumors, and papillary renal cell carcinoma, are linked to mutations in the MET gene. Numerous malignancies in humans have also been connected to MET overexpression and amplification.
A popular murine pro-B cell line in cancer and cell signaling studies is BaF3 cells. To boost their development and survival, they are cultivated on a medium enriched with interleukin-3 (IL-3). Rapidly multiplying suspension cells called BaF3 are frequently employed in research on receptor tyrosine kinase signaling cascades.
Hepatocyte growth factor (HGF) activates the c-MET receptor, which is crucial for tissue regeneration and cellular processes like migration and proliferation. However, the clinical application of HGF is limited due to its instability and poor recombinant expression. The researchers engineered a more stable and expressible HGF fragment, eNK1, and developed a dimerized version of eNK1 that showed significantly improved c-MET activation and cellular responses compared to the monomer. In this study, the researchers used BaF3-MET cells, a murine cell line transfected with human c-MET receptors, to analyze the binding affinity and activity of the eNK1 monomer and dimer. They found that the eNK1 dimer had a much lower IC50, indicating stronger binding affinity. This research highlights the potential of Creative Biogene's Human MET Stable Cell Line - BaF3 as a tool for similar studies on c-MET receptor activation and its implications for regenerative medicine
Figure 1. The researchers treated HUVEC cells with HGF, eNK1 monomer, or eNK1 dimer at various concentrations to assess c-MET activation. They used Western blot analysis to detect phosphorylated c-MET, Akt, and Erk and employed the PathHunter system to quantify c-MET activation through chemiluminescence. BaF3-MET cells were used for binding assays to measure affinity. (Hassannia H, et al., 2022)
1. Cancer Research: Using the human MET stable cell line Ba/F3, we studied the mutation and overexpression of the MET gene in hepatocellular carcinoma, head and neck tumors, and papillary renal cell carcinoma, revealing its specific mechanism in tumor occurrence and development.
2. Drug Screening and Evaluation: Using the Ba/F3 cell model, we tested and evaluated drugs targeting the MET receptor tyrosine kinase, studied its therapeutic effects in different types of tumors, and provided a basis for personalized treatment.
3. Signal Transduction Research: Using the MET stable cell line, we explored the dimerization and activation process of MET after binding to hepatocyte growth factor (HGF), and studied its signal transduction pathways in cell survival, embryonic development, cell migration and invasion.
4. Mutation Function Research: By studying the mutation form of the MET gene, we understand its carcinogenic potential in different types of tumors and provide a molecular basis for the development of new anti-cancer strategies.
5. Cell Proliferation and Survival: Using the rapid proliferation characteristics of Ba/F3 cells, we studied the effects of MET receptor activation on cell proliferation and survival, revealing its key role in cancer cell growth, and providing a reference for related treatments.
Customer Q&As
Human MET Stable Cell Line - What is the MET gene expression level of the BaF3 stable cell line? Does the expression of MET remain stable under different culture conditions?
A: Our Human MET stable cell line has undergone rigorous screening and verification to ensure stable expression of the MET gene. We verified the stability of the MET gene through PCR, Western blot and other methods, and conducted repeated tests at different time points and in different batches. Cells express MET under appropriate culture conditions and maintain stable expression levels.
What is the growth and proliferation performance of this cell line in the BaF3 background? Are there any special considerations related to the BaF3 cell line?
A: Our Human MET stable cell line exhibits normal growth and proliferation properties on a BaF3 background. We provide detailed culture guidelines to help customers overcome the potential unique growth requirements of the BaF3 cell line. Customers are advised to pay close attention to cell growth during use and follow our culture recommendations.
Has the BaF3 cell line for this product passed quality control inspection? What are the inspection standards?
A: Yes, our Human MET stable cell lines have passed strict quality control inspections. We verify cell lines according to international and internal standards, including stability of gene expression, cell morphology, contaminant detection, etc. We ensure that each batch of cell lines meets our quality standards to ensure our customers receive a high-quality product.
Ask a Question
Customer Reviews
Reliability
This human MET stable cell line expresses very reliably in BaF3 cells. In my experiments, I observed that these cells stably expressed MET receptor tyrosine kinase and responded significantly to HGF binding. This process is of great significance to cell survival, embryonic development, migration and invasion. This cell line provides a reliable platform for studying the activity of the MET signaling pathway and the pathogenesis of related diseases.
Stability
Stable cell lines expressing human MET in BaF3 cells showed outstanding performance. It was observed that after these cells were stimulated by HGF, the MET receptor dimerized and was activated, triggering a series of signal transduction reactions. This provides an ideal model for us to study the role of the MET signaling pathway in biological processes such as cell migration and invasion, and helps us better understand the pathogenesis of related diseases.
Professional service
The application of the human MET stable cell line in BaF3 cells has been very satisfactory. Through my experimental observations, these cells can stably express MET receptors and respond significantly to HGF binding. This provides an important tool for us to further study the role of the MET signaling pathway in malignant tumors such as hepatocellular carcinoma and head and neck tumors, and helps us find therapeutic targets for related diseases.
United Kingdom
02/22/2024
Write a Review